Vardhman Mahavir Medical College Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2008
NCT00694798
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Vardhman Mahavir Medical College And Safdarjung Hospital | V. M. Medical College and Safdarjang hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorhexidine (hibitane) (1 trial)

water (1 trial)

Drugs in Phase 1 Trials (1)

mycobacterium w vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Transitional Cell (Phase 1)

Neonatal Sepsis (Phase 3)

Sepsis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3